155 related articles for article (PubMed ID: 28510240)
1. [Warfarin should not be recommended to anyone with atrial fibrillation].
Samuelsson O; Saeed A
Lakartidningen; 2017 May; 114():. PubMed ID: 28510240
[No Abstract] [Full Text] [Related]
2. Bleeding risk on warfarin among elderly patients with atrial fibrillation.
Cowan A; Hylek EM
J Am Coll Cardiol; 2010 Mar; 55(9):932; author reply 932-3. PubMed ID: 20185052
[No Abstract] [Full Text] [Related]
3. Good old warfarin for stroke prevention in atrial fibrillation.
Verheugt FW
Lancet; 2006 Jun; 367(9526):1877-8. PubMed ID: 16765740
[No Abstract] [Full Text] [Related]
4. Pro: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Why warfarin should really be the drug of choice for stroke prevention in elderly patients with atrial fibrillation.
Mant JW
Thromb Haemost; 2008 Jul; 100(1):14-5. PubMed ID: 18612531
[No Abstract] [Full Text] [Related]
5. Warfarin in haemodialysis patients with atrial fibrillation: what benefit?
Yang F; Chou D; Schweitzer P; Hanon S
Europace; 2010 Dec; 12(12):1666-72. PubMed ID: 21045011
[TBL] [Abstract][Full Text] [Related]
6. [Complicated priorities regarding antithrombotic treatment of atrial fibrillation. Difficult to understand priority list in the national guidelines--new studies can make them clearer].
Mooe T
Lakartidningen; 2008 Sep 10-16; 105(37):2472-3. PubMed ID: 19006861
[No Abstract] [Full Text] [Related]
7. [Antithrombotic treatment in atrial fibrillation. Background to new recommendations and therapeutic alternative].
Själander A; Wallentin L; Rosenqvist M; Svensson P
Lakartidningen; 2008 Sep 10-16; 105(37):2478-80. PubMed ID: 19006862
[No Abstract] [Full Text] [Related]
8. New anticoagulants offer options beyond warfarin to reduce stroke risk.
Mitka M
JAMA; 2012 Nov; 308(17):1727-8. PubMed ID: 23117757
[No Abstract] [Full Text] [Related]
9. Between the Devil and the Deep Blue Sea--balancing the risks and potential benefits of warfarin for older people with atrial fibrillation.
Morgan SV
Age Ageing; 2004 Nov; 33(6):544-7. PubMed ID: 15501835
[No Abstract] [Full Text] [Related]
10. Physicians' perceptions of the benefits and risks of warfarin for patients with nonvalvular atrial fibrillation.
Bungard TJ; Ghali WA; McAlister FA; Buchan AM; Cave AJ; Hamilton PG; Mitchell LB; Shuaib A; Teo KK; Tsuyuki RT
CMAJ; 2001 Aug; 165(3):301-2. PubMed ID: 11517646
[No Abstract] [Full Text] [Related]
11. Stroke in heart failure: atrial fibrillation revisited?
Pullicino P; Homma S
J Stroke Cerebrovasc Dis; 2010 Jan; 19(1):1-2. PubMed ID: 20123219
[No Abstract] [Full Text] [Related]
12. Stroke prevention in atrial fibrillation: another step sideways.
Go AS; Singer DE
Lancet; 2008 Jan; 371(9609):278-80. PubMed ID: 18294981
[No Abstract] [Full Text] [Related]
13. Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation.
Hylek EM
Thromb Haemost; 2008 Jul; 100(1):16-7. PubMed ID: 18612532
[No Abstract] [Full Text] [Related]
14. Bleeding risk stratification models in deciding on anticoagulation in patients with atrial fibrillation: a useful complement to stroke risk stratification schema.
Kakar P; Lane D; Lip GY
Chest; 2006 Nov; 130(5):1296-9. PubMed ID: 17099002
[No Abstract] [Full Text] [Related]
15. Risk of anticoagulation for atrial fibrillation in the elderly.
DeSilvey DL
Am J Geriatr Cardiol; 2007; 16(5):325-6. PubMed ID: 17786064
[No Abstract] [Full Text] [Related]
16. The intersection of risk and benefit: is warfarin anticoagulation suitable for atrial fibrillation in patients on hemodialysis?
Sood MM; Komenda P; Sood AR; Rigatto C; Bueti J
Chest; 2009 Oct; 136(4):1128-1133. PubMed ID: 19809054
[TBL] [Abstract][Full Text] [Related]
17. Barriers to anticoagulation in patients with atrial fibrillation: changing physician-related factors.
Lane DA; Lip GY
Stroke; 2008 Jan; 39(1):7-9. PubMed ID: 18048849
[No Abstract] [Full Text] [Related]
18. Oral anticoagulant treatment in very elderly patients with atrial fibrillation.
Pengo V
Compr Ther; 2001; 27(1):7-10. PubMed ID: 11280859
[TBL] [Abstract][Full Text] [Related]
19. Balancing thromboembolic risk against vitamin K antagonist-related bleeding and accelerated calcification: is fondaparinux the Holy Grail for end-stage renal disease patients with atrial fibrillation?
Fiaccadori E; Maggiore U; Regolisti G
Nephrol Dial Transplant; 2013 Dec; 28(12):2923-8. PubMed ID: 24026242
[No Abstract] [Full Text] [Related]
20. Dabigatran etexilate (Pradaxa) for the treatment of atrial fibrillation.
Belavic JM
Nurse Pract; 2011 Sep; 36(9):6-7. PubMed ID: 21857210
[No Abstract] [Full Text] [Related]
[Next] [New Search]
